583 related articles for article (PubMed ID: 26292722)
1. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
Yoshino Y; Ishioka C
Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
[TBL] [Abstract][Full Text] [Related]
2. A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment.
Wakefield JG; Stephens DJ; Tavaré JM
J Cell Sci; 2003 Feb; 116(Pt 4):637-46. PubMed ID: 12538764
[TBL] [Abstract][Full Text] [Related]
3. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
Ougolkov AV; Fernandez-Zapico ME; Savoy DN; Urrutia RA; Billadeau DD
Cancer Res; 2005 Mar; 65(6):2076-81. PubMed ID: 15781615
[TBL] [Abstract][Full Text] [Related]
5. GSK-3 inhibitors induce chromosome instability.
Tighe A; Ray-Sinha A; Staples OD; Taylor SS
BMC Cell Biol; 2007 Aug; 8():34. PubMed ID: 17697341
[TBL] [Abstract][Full Text] [Related]
6. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
Park N; Baek HS; Chun YJ
PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
Ban JO; Oh JH; Son SM; Won D; Song HS; Han SB; Moon DC; Kang KW; Song MJ; Hong JT
Cancer Biol Ther; 2011 Aug; 12(4):288-96. PubMed ID: 21613824
[TBL] [Abstract][Full Text] [Related]
8. Activation of AKT1/GSK-3β/β-Catenin-TRIM11/Survivin Pathway by Novel GSK-3β Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model.
Darshit BS; Ramanathan M
Mol Neurobiol; 2016 Dec; 53(10):6716-6729. PubMed ID: 26660108
[TBL] [Abstract][Full Text] [Related]
9. LPLI inhibits apoptosis upstream of Bax translocation via a GSK-3beta-inactivation mechanism.
Zhang L; Zhang Y; Xing D
J Cell Physiol; 2010 Jul; 224(1):218-28. PubMed ID: 20333643
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of invasion by glycogen synthase kinase-3 beta inhibitors through dysregulation of actin re-organisation via down-regulation of WAVE2.
Yoshino Y; Suzuki M; Takahashi H; Ishioka C
Biochem Biophys Res Commun; 2015 Aug; 464(1):275-80. PubMed ID: 26116771
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
[TBL] [Abstract][Full Text] [Related]
12. GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis.
Lin CF; Chen CL; Chiang CW; Jan MS; Huang WC; Lin YS
J Cell Sci; 2007 Aug; 120(Pt 16):2935-43. PubMed ID: 17666435
[TBL] [Abstract][Full Text] [Related]
13. Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene.
Koh SH; Lee YB; Kim KS; Kim HJ; Kim M; Lee YJ; Kim J; Lee KW; Kim SH
Eur J Neurosci; 2005 Jul; 22(2):301-9. PubMed ID: 16045483
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
[TBL] [Abstract][Full Text] [Related]
16. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
Zhang JS; Herreros-Villanueva M; Koenig A; Deng Z; de Narvajas AA; Gomez TS; Meng X; Bujanda L; Ellenrieder V; Li XK; Kaufmann SH; Billadeau DD
Cell Death Dis; 2014 Mar; 5(3):e1142. PubMed ID: 24675460
[TBL] [Abstract][Full Text] [Related]
17. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
Ong CS; Zhou J; Ong CN; Shen HM
Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of GSK-3β reverses the pro-apoptotic effect of proadifen (SKF-525A) in HT-29 colon adenocarcinoma cells.
Jendželovský R; Koval J; Mikeš J; Papčová Z; Plšíková J; Fedoročko P
Toxicol In Vitro; 2012 Sep; 26(6):775-82. PubMed ID: 22683934
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of proanthocyanidins on anoxia-reoxygenation injury of myocardial cells mediated by the PI3K/Akt/GSK-3β pathway and mitochondrial ATP-sensitive potassium channel.
Hu Y; Li L; Yin W; Shen L; You B; Gao H
Mol Med Rep; 2014 Oct; 10(4):2051-8. PubMed ID: 25109283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
